India’s Expanding Vaccines Market Offers Promise To Global And Local Drug Firms (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Several drug companies are gearing up to go full throttle into the Indian vaccines market with programs that go beyond pushing products and seek to build up public health awareness on a larger scale. GSK, Sanofi, Merck, Novartis and Pfizer are in the fray with local players Serum Institute of India, Bharat Biotech, and Panacea Biotec.